First OA Biomarkers with an FDA Approved Qualification Plan

DDT-BMQ-000087: MRI-Based Cumulative Damage and Disease Activity (Qualification Plan Accepted 2025-03-12) 

DDT-BMQ-000086: End-Stage Knee Osteoarthritis (Letter of Intent Accepted 2019-12-20)

DDT-BMQ-000159: Probability Score for Developing End-Stage Knee Osteoarthritis (p‑esKOA; Letter of Intent Resubmitted)